Breaking News Instant updates and real-time market news.

ARPO

Aerpio Pharmaceuticals

$1.22 /

-2.915 (-70.58%)

07:23
03/19/19
03/19
07:23
03/19/19
07:23

Aerpio selloff overly discounts ongoing glaucoma program, says Cantor Fitzgerald

Cantor Fitzgerald analyst Eliana Merle lowered her price target for Aerpio Pharmaceuticals to $3 from $8 after the company announced the Time-2B Phase 2b study missed its primary endpoint in diabetic retinopathy. The shares are currently trading close to cash, which overly discounts the potential for partner milestones and the ongoing glaucoma program, Merle tells investors in a research note. She sees a favorable risk/reward into potential updates on Aerpio's other programs and keeps an Overweight rating on the name.

ARPO Aerpio Pharmaceuticals
$1.22 /

-2.915 (-70.58%)

03/19/19 H.C. Wainwright
Aerpio Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
03/18/19 Guggenheim
Aerpio Pharmaceuticals downgraded to Neutral from Buy at Guggenheim
03/18/19 National Securities
Aerpio Pharmaceuticals downgraded to Neutral from Buy at National Securities
01/18/19 Cantor Fitzgerald
Cantor starts Aerpio at Overweight, sees potential 300%-500% upside

TODAY'S FREE FLY STORIES

Earnings
B&G Foods reports Q4 adjusted EPS 28c, consensus 29c » 16:12
02/25/20
02/25
16:12
02/25/20
16:12
BGS

B&G Foods

$12.78 /

-0.33 (-2.52%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Planet Fitness reports Q4 adjusted EPS 44c, consensus 41c » 16:11
02/25/20
02/25
16:11
02/25/20
16:11
PLNT

Planet Fitness

$81.42 /

-2.96 (-3.51%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
SmileDirectClub down 17.9% after reporting Q4 results, giving FY20 guidance  16:11
02/25/20
02/25
16:11
02/25/20
16:11
SDC

SmileDirectClub

$11.33 /

-0.51 (-4.31%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Evolent Health sees Q1 revenue $233.5M-$245.5M, consensus $234.76M » 16:11
02/25/20
02/25
16:11
02/25/20
16:11
EVH

Evolent Health

$10.12 /

-1.19 (-10.52%)

The components of revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Red Robin reports Q4 comp restaurant revenue up 1.3%  16:11
02/25/20
02/25
16:11
02/25/20
16:11
RRGB

Red Robin

$31.25 /

-3.91 (-11.12%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Exelixis reports Q4 EPS 26c, consensus 16c » 16:11
02/25/20
02/25
16:11
02/25/20
16:11
EXEL

Exelixis

$19.43 /

-0.75 (-3.72%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
SmileDirectClub says achieving profitability a 'big focus' in 2020 » 16:11
02/25/20
02/25
16:11
02/25/20
16:11
SDC

SmileDirectClub

$11.29 /

-0.55 (-4.65%)

SmileDirectClub CFO Kyle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Red Robin sees FY20 comparable restaurant revenue growth in low single digits » 16:10
02/25/20
02/25
16:10
02/25/20
16:10
RRGB

Red Robin

$31.25 /

-3.91 (-11.12%)

Sees FY20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Anworth Mortgage reports Q4 core EPS 7c, one estimate 11c » 16:10
02/25/20
02/25
16:10
02/25/20
16:10
ANH

Anworth Mortgage

$3.63 /

-0.09 (-2.42%)

At December 31, 2019, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
Earnings
Kura Oncology reports Q4 EPS (39c), consensus (41c) » 16:10
02/25/20
02/25
16:10
02/25/20
16:10
KURA

Kura Oncology

$12.47 /

-0.07 (-0.56%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Evolent Health sees FY20 revenue $935.0M-$985.0, consensus $935.79M » 16:10
02/25/20
02/25
16:10
02/25/20
16:10
EVH

Evolent Health

$10.14 /

-1.17 (-10.34%)

The components of revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
SmileDirectClub sees FY20 revenue $1B-$1.1B, consensus $1.14B » 16:10
02/25/20
02/25
16:10
02/25/20
16:10
SDC

SmileDirectClub

$11.30 /

-0.54 (-4.56%)

Sees FY20 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Huya downgraded to Neutral from Buy at Goldman Sachs » 16:10
02/25/20
02/25
16:10
02/25/20
16:10
HUYA

Huya

$19.35 /

-0.12 (-0.62%)

Goldman Sachs downgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Red Robin reports Q4 adjusted EPS (36c), consensus (16c) » 16:10
02/25/20
02/25
16:10
02/25/20
16:10
RRGB

Red Robin

$31.25 /

-3.91 (-11.12%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Syndicate
Freshpet files to sell $215M in common stock » 16:09
02/25/20
02/25
16:09
02/25/20
16:09
FRPT

Freshpet

$73.82 /

+0.14 (+0.19%)

BofA Securities is acting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Salesforce sees Q1 adjusted EPS 70c-71c, consensus 55c » 16:09
02/25/20
02/25
16:09
02/25/20
16:09
CRM

Salesforce

$180.99 /

-4.92 (-2.65%)

Sees Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Veracyte sees FY20 revenue $138M-$142M, consensus $136.41M » 16:09
02/25/20
02/25
16:09
02/25/20
16:09
VCYT

Veracyte

$23.60 /

-0.24 (-1.01%)

Sees FY20 net cash used…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Morgan Stanley healthcare analyst to hold an analyst/industry conference call » 16:09
02/25/20
02/25
16:09
02/25/20
16:09
CAH

Cardinal Health

$55.64 /

-2.5 (-4.30%)

Healthcare Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Virgin Galactic reports Q4 comprehensive loss of ($72.7M) vs. ($45.8M) last year » 16:09
02/25/20
02/25
16:09
02/25/20
16:09
SPCE

Virgin Galactic

$34.40 /

+0.24 (+0.70%)

Reports Q4 revenue $529K…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Iovance Biotherapeutics reports Q4 EPS (50c), consensus (91c) » 16:09
02/25/20
02/25
16:09
02/25/20
16:09
IOVA

Iovance Biotherapeutics

$31.32 /

+6.63 (+26.85%)

At December 31, 2019, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Veracyte reports Q4 EPS (15c), consensus (7c) » 16:09
02/25/20
02/25
16:09
02/25/20
16:09
VCYT

Veracyte

$23.65 /

-0.19 (-0.80%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Evertec sees FY20 adjusted EPS $2.00-$2.06, consensus $2.17 » 16:09
02/25/20
02/25
16:09
02/25/20
16:09
EVTC

Evertec

$31.64 /

-0.37 (-1.16%)

Sees FY20 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Salesforce sees FY21 adjusted EPS $3.16-$3.18, consensus $3.10  16:09
02/25/20
02/25
16:09
02/25/20
16:09
CRM

Salesforce

$181.59 /

-4.32 (-2.32%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Regional Management reports Q4 EPS $1.38, consensus $1.11 » 16:08
02/25/20
02/25
16:08
02/25/20
16:08
RM

Regional Management

$27.51 /

-0.76 (-2.69%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
SmileDirectClub reports Q4 EPS (25c), consensus (9c) » 16:08
02/25/20
02/25
16:08
02/25/20
16:08
SDC

SmileDirectClub

$11.33 /

-0.51 (-4.31%)

Reports Q4 revenue $197M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.